It remains to be investigated whether there is any potential difference in clinical outcome between non-IG::MYC translocation positive DLBCL with high and low MYC protein expression, and whether those with high MYC expression are similar to cases with IG::MYC in their clinical outcome. This evidence concerns the gene MYC and diffuse large B-cell lymphoma.